Skip to content

Drug interactions

Idelalisib + Paclitaxel

Severity: Major

Idelalisib and Paclitaxel: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Idelalisib is a strong CYP3A inhibitor and may increase paclitaxel exposure, since CYP3A4 and CYP2C8 both clear paclitaxel. Increased myelosuppression and neuropathy are possible.

What this interaction means in plain words

Idelalisib and Paclitaxel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Idelalisib belongs to Oncology; Paclitaxel belongs to Oncology.

Evidence level: Low

Why it happens

Strong CYP3A inhibition reduces paclitaxel metabolism.

What to do

Avoid if an alternative is available; otherwise monitor blood counts and neuropathy and reduce paclitaxel dose for toxicity.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Idelalisib and Paclitaxel, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Idelalisib with Paclitaxel?

MediHelp rates the interaction as major. Idelalisib and Paclitaxel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Idelalisib is a strong CYP3A inhibitor and may increase paclitaxel exposure, since CYP3A4 and CYP2C8 both clear paclitaxel. Increased myelosuppression and neuropathy are possible.

How serious is the interaction between Idelalisib and Paclitaxel?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid if an alternative is available; otherwise monitor blood counts and neuropathy and reduce paclitaxel dose for toxicity.

What other medicines interact with Paclitaxel?

MediHelp also lists interactions of Paclitaxel with, for example, Adenovirus types 4 and 7 live, Cobicistat, Cyclosporine. The full list is on the Paclitaxel page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in